Work

NANORAY-1100: A phase I study of NBTXR3 activated by radiotherapy in patients with advanced cancers treated with anti-PD-1 therapy.

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.5_suppl.tps86

Authors: Colette J. Shen, Katherine LaRoque Jameson, Jared Weiss, Trevor Hackman, Robert Dixon, Jason A. Akulian, Alexander T. Pearson, Jessica Frakes, Patricia Said, Tanguy Y. Seiwert

Institutions: University of North Carolina at Chapel Hill, Vanderbilt University, Vanderbilt University Medical Center, University of North Carolina Hospitals, University of Chicago, Moffitt Cancer Center, Nanobiotix (France)

Language: English

Topic: Cancer Immunotherapy and Biomarkers

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3004453240

Cites:

Cited by: 4

Related to: 10